Tekmira Pharmaceuticals Corp (NASDAQ:TKMR)

11.71
Delayed Data
As of Jul 01
 -0.15 / -1.26%
Today’s Change
8.86
Today|||52-Week Range
29.93
-22.71%
Year-to-Date

Today’s Trading

Previous close11.86
Today’s open11.86
Day’s range11.62 - 12.14
Volume309,264
Average volume (3 months)710,902
Market cap$642.9M
Dividend yield--
Data as of 3:59pm ET, 07/01/2015

Growth & Valuation

Earnings growth (last year)-95.65%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-3.31%
P/E ratio--
Price/Sales22.17
Price/Book3.02

Competitors

 Today’s
change
Today’s
% change
SRNESorrento Therapeutic...-0.41-2.33%
CORTCorcept Therapeutics...-0.01-0.17%
ADXSAdvaxis Inc-1.41-6.94%
OREXOrexigen Therapeutic...-0.02-0.40%
Data as of 3:59pm ET, 07/01/2015

Financials

Next reporting dateAugust 13, 2015
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$15.0M
Annual profit (last year)-$38.8M
Net profit margin-259.73%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Operating Officer
Patrick T. Higgins
Corporate headquarters
Burnaby, British Columbia

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers